NTRA
Natera, Inc.$202.36-2.09 (-1.02%)Prev Close$204.39·MCap$29.11B·P/E—·Vol1.13M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
137
$338.77M
◆
Net Activity
Net Seller
$338.77M
●
Active Insiders
12
last 12 mo
Over the past 12 months, insider activity at Natera, Inc. (NTRA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 137 insider sales totaling $338.77M. The most recent insider transaction was by Sheena Jonathan (director, other: CO-FOUNDER), who sold $149.7K worth of shares on Apr 21, 2026. Natera, Inc. operates in the Healthcare sector, within the Medical - Diagnostics & Research industry, with a market cap of $29.11B.
NTRA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 750 | $199.59 | $149.7K | 20,282 |
| Apr 3, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $202.30 | $606.9K | 149,834 |
| Apr 3, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 8,400 | $203.31 | $1.71M | 232,985 |
| Mar 20, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 4,335 | $198.77 | $861.7K | 262,025 |
| Mar 17, 2026 | Chapman Rowan E | director | Sell | 122 | $191.38 | $23.3K | 5,752 |
| Mar 16, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 200,000 | $191.42 | $38.28M | 2,377,681 |
| Mar 11, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 785 | $204.13 | $160.2K | 63,354 |
| Mar 11, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,623 | $204.13 | $1.15M | 156,607 |
| Mar 11, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 707 | $204.13 | $144.3K | 189,199 |
| Mar 11, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 915 | $204.13 | $186.8K | 150,882 |
| Mar 11, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,745 | $204.13 | $356.2K | 233,285 |
| Mar 11, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 127 | $204.13 | $25.9K | 262,325 |
| Mar 10, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 8,398 | $196.08 | $1.65M | 241,283 |
| Feb 4, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 6,939 | $227.83 | $1.58M | 57,791 |
| Feb 4, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 89,924 | $230.72 | $20.75M | 206,549-30% |
| Feb 4, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,179 | $230.77 | $272.1K | 180,496 |
| Feb 4, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,543 | $231.24 | $1.05M | 141,528 |
| Feb 4, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,334 | $230.77 | $307.8K | 223,813 |
| Feb 4, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 435 | $230.77 | $100.4K | 263,161 |
| Feb 3, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 6,939 | $227.83 | $1.58M | 0 |
| Feb 3, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 3,594 | $231.02 | $830.3K | 0 |
| Feb 3, 2026 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,334 | $230.77 | $307.8K | 0 |
| Feb 3, 2026 | Sheena Jonathan | Director | Sell | 435 | $230.77 | $100.4K | 0 |
| Feb 2, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 90,024 | $230.72 | $20.77M | 0 |
| Feb 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,639 | $231.20 | $1.07M | 0 |
| Jan 29, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 5,064 | $235.38 | $1.19M | 63,339 |
| Jan 29, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,970 | $238.78 | $1.43M | 216,828 |
| Jan 29, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,712 | $238.98 | $409.1K | 176,468 |
| Jan 29, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,213 | $238.98 | $528.9K | 143,686 |
| Jan 29, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,886 | $239.01 | $450.8K | 226,147 |
| Jan 29, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 482 | $239.39 | $115.4K | 263,787 |
| Jan 27, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,064 | $235.38 | $1.19M | 0 |
| Jan 27, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,970 | $238.78 | $1.43M | 0 |
| Jan 27, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 928 | $237.66 | $220.6K | 0 |
| Jan 27, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,213 | $238.98 | $528.9K | 0 |
| Jan 27, 2026 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,886 | $239.01 | $450.8K | 0 |
| Jan 27, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,772 | $242.81 | $430.3K | 22,332 |
| Jan 23, 2026 | Sheena Jonathan | Director | Sell | 1,500 | $243.94 | $365.9K | 0 |
| Jan 22, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 60,521 | $239.53 | $14.50M | 99,776-38% |
| Jan 22, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 71,932 | $234.74 | $16.89M | 217,354 |
| Jan 22, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 17,806 | $234.74 | $4.18M | 177,591 |
| Jan 22, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 23,205 | $234.74 | $5.45M | 144,992 |
| Jan 22, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 19,234 | $234.74 | $4.51M | 226,615 |
| Jan 22, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 6,051 | $234.59 | $1.42M | 267,050 |
| Jan 20, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 61,123 | $239.49 | $14.64M | 0 |
| Jan 20, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 73,522 | $234.74 | $17.26M | 0 |
| Jan 20, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 18,145 | $234.74 | $4.26M | 0 |
| Jan 20, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 23,498 | $234.74 | $5.52M | 0 |
| Jan 20, 2026 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 19,672 | $234.74 | $4.62M | 0 |
| Jan 20, 2026 | Sheena Jonathan | Director | Sell | 6,144 | $234.60 | $1.44M | 0 |
Showing 1–50 of 531
1 / 11
...
NTRA Insider Buying Activity
The following table shows recent insider purchases of Natera, Inc. (NTRA) stock reported via SEC Form 4 filings.
No insider buying activity found for NTRA in the last 12 months.
NTRA Insider Selling Activity
The following table shows recent insider sales of Natera, Inc. (NTRA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 750 | $199.59 | $149.7K | 20,282 |
| Apr 3, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $202.30 | $606.9K | 149,834 |
| Apr 3, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 8,400 | $203.31 | $1.71M | 232,985 |
| Mar 20, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 4,335 | $198.77 | $861.7K | 262,025 |
| Mar 17, 2026 | Chapman Rowan E | director | Sell | 122 | $191.38 | $23.3K | 5,752 |
| Mar 16, 2026 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 200,000 | $191.42 | $38.28M | 2,377,681 |
| Mar 11, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 785 | $204.13 | $160.2K | 63,354 |
| Mar 11, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,623 | $204.13 | $1.15M | 156,607 |
| Mar 11, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 707 | $204.13 | $144.3K | 189,199 |
| Mar 11, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 915 | $204.13 | $186.8K | 150,882 |
| Mar 11, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,745 | $204.13 | $356.2K | 233,285 |
| Mar 11, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 127 | $204.13 | $25.9K | 262,325 |
| Mar 10, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 8,398 | $196.08 | $1.65M | 241,283 |
| Feb 4, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 6,939 | $227.83 | $1.58M | 57,791 |
| Feb 4, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 89,924 | $230.72 | $20.75M | 206,549-30% |
| Feb 4, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,179 | $230.77 | $272.1K | 180,496 |
| Feb 4, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,543 | $231.24 | $1.05M | 141,528 |
| Feb 4, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,334 | $230.77 | $307.8K | 223,813 |
| Feb 4, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 435 | $230.77 | $100.4K | 263,161 |
| Feb 3, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 6,939 | $227.83 | $1.58M | 0 |
| Feb 3, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 3,594 | $231.02 | $830.3K | 0 |
| Feb 3, 2026 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,334 | $230.77 | $307.8K | 0 |
| Feb 3, 2026 | Sheena Jonathan | Director | Sell | 435 | $230.77 | $100.4K | 0 |
| Feb 2, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 90,024 | $230.72 | $20.77M | 0 |
| Feb 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,639 | $231.20 | $1.07M | 0 |
| Jan 29, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 5,064 | $235.38 | $1.19M | 63,339 |
| Jan 29, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,970 | $238.78 | $1.43M | 216,828 |
| Jan 29, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,712 | $238.98 | $409.1K | 176,468 |
| Jan 29, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,213 | $238.98 | $528.9K | 143,686 |
| Jan 29, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,886 | $239.01 | $450.8K | 226,147 |
| Jan 29, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 482 | $239.39 | $115.4K | 263,787 |
| Jan 27, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,064 | $235.38 | $1.19M | 0 |
| Jan 27, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,970 | $238.78 | $1.43M | 0 |
| Jan 27, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 928 | $237.66 | $220.6K | 0 |
| Jan 27, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,213 | $238.98 | $528.9K | 0 |
| Jan 27, 2026 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,886 | $239.01 | $450.8K | 0 |
| Jan 27, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,772 | $242.81 | $430.3K | 22,332 |
| Jan 23, 2026 | Sheena Jonathan | Director | Sell | 1,500 | $243.94 | $365.9K | 0 |
| Jan 22, 2026 | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 60,521 | $239.53 | $14.50M | 99,776-38% |
| Jan 22, 2026 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 71,932 | $234.74 | $16.89M | 217,354 |
| Jan 22, 2026 | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 17,806 | $234.74 | $4.18M | 177,591 |
| Jan 22, 2026 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 23,205 | $234.74 | $5.45M | 144,992 |
| Jan 22, 2026 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 19,234 | $234.74 | $4.51M | 226,615 |
| Jan 22, 2026 | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 6,051 | $234.59 | $1.42M | 267,050 |
| Jan 20, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 61,123 | $239.49 | $14.64M | 0 |
| Jan 20, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 73,522 | $234.74 | $17.26M | 0 |
| Jan 20, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 18,145 | $234.74 | $4.26M | 0 |
| Jan 20, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 23,498 | $234.74 | $5.52M | 0 |
| Jan 20, 2026 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 19,672 | $234.74 | $4.62M | 0 |
| Jan 20, 2026 | Sheena Jonathan | Director | Sell | 6,144 | $234.60 | $1.44M | 0 |
NTRA Insiders
Similar Stocks to NTRA
TMO
Thermo Fisher Scientific Inc.
$470.41+0.47%
$195.48B
DHR
Danaher Corporation
$178.89-0.90%
$138.35B
IDXX
IDEXX Laboratories, Inc.
$568.37-1.14%
$46.43B
IQV
IQVIA Holdings Inc.
$159.84-2.34%
$30.00B
MTD
Mettler-Toledo International Inc.
$1263.01-0.87%
$26.92B
DGX
Quest Diagnostics Incorporated
$195.18-0.78%
$22.69B
LH
Labcorp Holdings Inc.
$260.15-1.25%
$22.53B
ILMN
Illumina, Inc.
$126.78-1.37%
$20.18B